Clinical Study
Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome
Table 3
Two-year clinical outcomes.
| | Before PSM | After PSM | LMCA (n = 155) | Non-LMCA (n = 6274) | p value | LMCA (n = 150) | Non-LMCA (n = 150) | value |
| All-cause death | 4 (2.6) | 82 (1.3) | 0.153 | 3 (2.0) | 2 (1.3) | 1.000 | Cardiac death | 4 (2.6) | 47 (0.7) | 0.034 | 3 (2.0) | 0 (0) | 0.247 | Myocardial infarction | 11 (7.1) | 116 (1.8) | <0.001 | 11 (3.0) | 2 (1.3) | 0.011 | Target vessel related | 8 (5.2) | 52 (0.8) | <0.001 | 8 (5.3) | 3 (2.0) | 0.125 | Target lesion related | 2 (1.3) | 31 (0.5) | 0.188 | 2 (1.3) | 1 (0.7) | 1.000 | Unplanned revascularization | 10 (6.5) | 546 (8.7) | 0.325 | 10 (6.7) | 15 (10.0) | 0.296 | Target vessel related | 9 (5.8) | 146 (94.2) | 0.722 | 9 (6.0) | 9 (6.0) | 1.000 | Target lesion related | 7 (4.5) | 148 (95.5) | 0.755 | 7 (4.7) | 7 (4.7) | 1.000 | In-stent thrombosis | 7 (4.5) | 51 (0.8) | <0.001 | 6 (4.0) | 2 (1.3) | 0.282 | Stroke | 6 (3.9) | 88 (1.4) | 0.025 | 5 (3.3) | 6 (4.0) | 0.759 | Bleeding | 11 (7.1) | 401 (6.4) | 0.723 | 11 (7.3) | 6 (4.0) | 0.212 | MACCE | 24 (15.5) | 768 (12.2) | 0.225 | 22 (14.7) | 23 (15.3) | 0.872 |
|
|
MACCE = major adverse cardiac and cerebrovascular events.
|